Company news

OraSure Technologies, Inc. news in 2021

OraSure Technologies, Inc.'s news releases, calls and decks from 2021, newest first.

View company

OraSure Technologies Announces 2022 Annual Meeting Date

December 13, 2021

OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus

November 29, 2021

OraSure Technologies to Present at Upcoming Investor Conferences

November 18, 2021

OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

November 8, 2021

OraSure Technologies Appoints Two New Members to the Board of Directors

November 7, 2021

OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

November 2, 2021

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

November 1, 2021

OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5: 00 p.m. ET

October 26, 2021

OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test

October 3, 2021

OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver

September 22, 2021

OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

September 19, 2021

OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

September 1, 2021

OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

August 2, 2021

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5: 00 p.m. ET

July 26, 2021

OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

June 16, 2021

OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

June 13, 2021

OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

June 6, 2021

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

May 27, 2021

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

May 17, 2021

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

May 16, 2021

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

May 11, 2021

OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

May 4, 2021

OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

March 29, 2021

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

February 28, 2021

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing

January 27, 2021

OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program

January 25, 2021

OraSure Technologies Announces 2021 Annual Meeting Date

January 7, 2021

Calls in 2021

Decks in 2021